Literature DB >> 8729224

Symptomatic vulvovaginitis due to fluconazole-resistant Candida albicans in a female who was not infected with human immunodeficiency virus.

J D Sobel1, J A Vazquez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8729224     DOI： 10.1093/clinids/22.4.726

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  15 in total

1.  Management of recurrent vulvovaginal candidiasis: unresolved issues.

Authors:  Jack D Sobel
Journal:  Curr Infect Dis Rep       Date:  2006-11       Impact factor: 3.725

Review 2.  Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

Authors:  T C White; K A Marr; R A Bowden
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

Review 3.  Azole resistance in Candida.

Authors:  D W Denning; G G Baily; S V Hood
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-04       Impact factor: 3.267

4.  Efficacy of D0870 treatment of experimental Candida vaginitis.

Authors:  P L Fidel; J L Cutright; J D Sobel
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

5.  Antimicrobial Resistance in Vulvovaginitis.

Authors:  Jack D. Sobel
Journal:  Curr Infect Dis Rep       Date:  2001-12       Impact factor: 3.725

6.  Vaginal yeasts in the era of "over the counter" antifungals.

Authors:  P P Walker; M T Reynolds; H R Ashbee; C Brown; E G Evans
Journal:  Sex Transm Infect       Date:  2000-12       Impact factor: 3.519

7.  Susceptibility profile of vaginal yeast isolates from Brazil.

Authors:  M A Ribeiro; R Dietze; C R Paula; D A Da Matta; A L Colombo
Journal:  Mycopathologia       Date:  2001       Impact factor: 2.574

8.  Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases.

Authors:  Sandra S Richter; Rudolph P Galask; Shawn A Messer; Richard J Hollis; Daniel J Diekema; Michael A Pfaller
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

Review 9.  Candida parapsilosis, an emerging fungal pathogen.

Authors:  David Trofa; Attila Gácser; Joshua D Nosanchuk
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

10.  Fluconazole susceptibility of vaginal isolates obtained from women with complicated Candida vaginitis: clinical implications.

Authors:  J D Sobel; M Zervos; B D Reed; T Hooton; D Soper; P Nyirjesy; M W Heine; J Willems; H Panzer
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.